Recent Exposure to Four-Factor Prothrombin Complex Concentrate (4F-PCC) is Associated with Intracardiac Thrombus during Liver Transplantation.

被引：0
|
作者：
Misel, M. [1 ,2 ]
Schnickel, G. [1 ]
Berumen, J. [1 ]
Sanchez, R. [3 ]
Mekeel, K. [1 ]
机构：
[1] UC San Diego Hlth, Div Transplant & Hepatobiliary Surg, La Jolla, CA USA
[2] UC San Diego Hlth, Pharm Inpatient Serv, La Jolla, CA USA
[3] UC San Diego Hlth, Anesthesiol, La Jolla, CA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A241
引用
收藏
页码：558 / 558
页数：1
相关论文
共 50 条
  • [31] Four-Factor Prothrombin Complex Concentrate (4-PCC) Effectively Reverses Edoxaban Induced Bleeding In a Rabbit Model Of Acute Injury
    Herzog, Eva
    Kaspereit, Franz
    Krege, Wilfried
    Pragst, Ingo
    Morishima, Yoshiyuki
    Schulte, Stefan
    Dickneite, Gerhard
    BLOOD, 2013, 122 (21)
  • [32] THREE- VS FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN WARFARIN-ASSOCIATED INTRACRANIAL HEMORRHAGE
    Fischer, Daniel
    Fontaine, Gabriel
    Sorensen, Jeff
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [33] Transient seroconversions for anti-HAV in patients after the administration of a prothrombin complex concentrate (PCC), and liver transplantation.
    Gröner, A
    Sowade, O
    Egger, K
    Plogmann, B
    Lorenz, R
    BLOOD, 1998, 92 (10) : 105B - 105B
  • [34] Four-factor prothrombin complex concentrate reverses apixaban-associated bleeding in a rabbit model of acute hemorrhage
    Herzog, E.
    Kaspereit, F.
    Krege, W.
    Mueller-Cohrs, J.
    Doerr, B.
    Niebl, P.
    Dickneite, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (12) : 2220 - 2226
  • [35] Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for the Emergent Management of Warfarin-Associated Intracranial Hemorrhage
    Fischer, Daniel
    Sorensen, Jeffrey
    Fontaine, Gabriel V.
    NEUROCRITICAL CARE, 2018, 28 (01) : 43 - 50
  • [36] PERIOPERATIVE 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE VERSUS FACTOR VITA IN LIVER TRANSPLANTATION
    Shakowski, Courtney
    Detry, Jason
    MacLaren, Robert
    Lyda, Clark
    Kiser, Tyree
    Mandell, Susan
    Mueller, Scott
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [37] Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for the Emergent Management of Warfarin-Associated Intracranial Hemorrhage
    Daniel Fischer
    Jeffrey Sorensen
    Gabriel V. Fontaine
    Neurocritical Care, 2018, 28 : 43 - 50
  • [38] Impact of timing and dosing of four-factor prothrombin complex concentrate administration on outcomes in warfarin-associated intracranial hemorrhage
    Cicci, Corey D.
    Weiss, Ashley
    Dang, Cathyyen
    Stanton, Matthew
    Feldman, Ryan
    PHARMACOTHERAPY, 2022, 42 (05): : 366 - 374
  • [39] Effective Reversal of Edoxaban-associated Bleeding with Four-factor Prothrombin Complex Concentrate in a Rabbit Model of Acute Hemorrhage
    Herzog, Eva
    Kaspereit, Franz
    Krege, Wilfried
    Doerr, Baerbel
    Mueller-Cohrs, Jochen
    Pragst, Ingo
    Morishima, Yoshiyuki
    Dickneite, Gerhard
    ANESTHESIOLOGY, 2015, 122 (02) : 387 - 398
  • [40] Incidence of thromboembolic events after four-factor prothrombin complex concentrate (PCC4) administration for emergent reversal of warfarin or direct oral anticoagulants in intracranial hemorrhage
    Scott, Rachael
    PHARMACOTHERAPY, 2017, 37 (12): : E149 - E150
12345